The Marketing Strategy of Generic Medicines in Taiwan,under the Global Budgets of the BNHI –Using Statin as an example

碩士 === 國立陽明大學 === 醫務管理研究所 === 93 === Abstract Recently, healthcare costs in every country keep increasing. Thus, governments are encouraging the usage of generic drugs. BNHI prevents the enlargement of financial problems via carrying out global budget (GB) payment reforms. The implementation of GB h...

Full description

Bibliographic Details
Main Authors: Shih-Jing Hsiao, 蕭詩婧
Other Authors: Guang-Yang Yang
Format: Others
Language:zh-TW
Published: 2005
Online Access:http://ndltd.ncl.edu.tw/handle/26045520162817995273
id ndltd-TW-093YM005528019
record_format oai_dc
spelling ndltd-TW-093YM0055280192016-06-06T04:11:02Z http://ndltd.ncl.edu.tw/handle/26045520162817995273 The Marketing Strategy of Generic Medicines in Taiwan,under the Global Budgets of the BNHI –Using Statin as an example 總額預算下,台灣學名藥市場的策略研究----以降血脂劑(statin)為例 Shih-Jing Hsiao 蕭詩婧 碩士 國立陽明大學 醫務管理研究所 93 Abstract Recently, healthcare costs in every country keep increasing. Thus, governments are encouraging the usage of generic drugs. BNHI prevents the enlargement of financial problems via carrying out global budget (GB) payment reforms. The implementation of GB has substantial impacts on the pharmaceutical market. This study uses questionnaires and IMS selling data to analyze strategies. Three hypotheses are suggested as follows: (1) After GB, the sales of pharmacies will increase. (2) After GB, every healthcare industry will select drugs according to prices. (3) Pharmaceutical manufacturers would invest more capital in research and development (R&D). The larger pharmaceutical companies will survive and smaller ones will go bankrupt. Through the examination of selling data of Simavastatin and Lovastatin, evidence suggests that generic drug sales have increased significantly after the implementation of GB. The first industry that entered the market has even more advantage than others. It will be studied in the future whether the local industries will invade the market of original industries due to the implementation of GB. Finally, the researcher has found that the profit margin of generic drugs of total pharmaceutical industries will be slight, large industries will have a larger developing space, and every medical institution will has a low-price selective effect upon generic drugs. The pharmaceutical industries of generic drugs will have a strong ability of R&D and marketing channels. There are three attacking strategies to be chosen, investing in R&D, enhancing quality and increasing market competition. When facing the attacks of competitors, there are four defending strategies, weakening the points of attacking, sponsoring activities, diverting markets and distinguishing between products. Guang-Yang Yang 楊冠洋 錢慶文 2005 學位論文 ; thesis 84 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 碩士 === 國立陽明大學 === 醫務管理研究所 === 93 === Abstract Recently, healthcare costs in every country keep increasing. Thus, governments are encouraging the usage of generic drugs. BNHI prevents the enlargement of financial problems via carrying out global budget (GB) payment reforms. The implementation of GB has substantial impacts on the pharmaceutical market. This study uses questionnaires and IMS selling data to analyze strategies. Three hypotheses are suggested as follows: (1) After GB, the sales of pharmacies will increase. (2) After GB, every healthcare industry will select drugs according to prices. (3) Pharmaceutical manufacturers would invest more capital in research and development (R&D). The larger pharmaceutical companies will survive and smaller ones will go bankrupt. Through the examination of selling data of Simavastatin and Lovastatin, evidence suggests that generic drug sales have increased significantly after the implementation of GB. The first industry that entered the market has even more advantage than others. It will be studied in the future whether the local industries will invade the market of original industries due to the implementation of GB. Finally, the researcher has found that the profit margin of generic drugs of total pharmaceutical industries will be slight, large industries will have a larger developing space, and every medical institution will has a low-price selective effect upon generic drugs. The pharmaceutical industries of generic drugs will have a strong ability of R&D and marketing channels. There are three attacking strategies to be chosen, investing in R&D, enhancing quality and increasing market competition. When facing the attacks of competitors, there are four defending strategies, weakening the points of attacking, sponsoring activities, diverting markets and distinguishing between products.
author2 Guang-Yang Yang
author_facet Guang-Yang Yang
Shih-Jing Hsiao
蕭詩婧
author Shih-Jing Hsiao
蕭詩婧
spellingShingle Shih-Jing Hsiao
蕭詩婧
The Marketing Strategy of Generic Medicines in Taiwan,under the Global Budgets of the BNHI –Using Statin as an example
author_sort Shih-Jing Hsiao
title The Marketing Strategy of Generic Medicines in Taiwan,under the Global Budgets of the BNHI –Using Statin as an example
title_short The Marketing Strategy of Generic Medicines in Taiwan,under the Global Budgets of the BNHI –Using Statin as an example
title_full The Marketing Strategy of Generic Medicines in Taiwan,under the Global Budgets of the BNHI –Using Statin as an example
title_fullStr The Marketing Strategy of Generic Medicines in Taiwan,under the Global Budgets of the BNHI –Using Statin as an example
title_full_unstemmed The Marketing Strategy of Generic Medicines in Taiwan,under the Global Budgets of the BNHI –Using Statin as an example
title_sort marketing strategy of generic medicines in taiwan,under the global budgets of the bnhi –using statin as an example
publishDate 2005
url http://ndltd.ncl.edu.tw/handle/26045520162817995273
work_keys_str_mv AT shihjinghsiao themarketingstrategyofgenericmedicinesintaiwanundertheglobalbudgetsofthebnhiusingstatinasanexample
AT xiāoshījìng themarketingstrategyofgenericmedicinesintaiwanundertheglobalbudgetsofthebnhiusingstatinasanexample
AT shihjinghsiao zǒngéyùsuànxiàtáiwānxuémíngyàoshìchǎngdecèlüèyánjiūyǐjiàngxuèzhījìstatinwèilì
AT xiāoshījìng zǒngéyùsuànxiàtáiwānxuémíngyàoshìchǎngdecèlüèyánjiūyǐjiàngxuèzhījìstatinwèilì
AT shihjinghsiao marketingstrategyofgenericmedicinesintaiwanundertheglobalbudgetsofthebnhiusingstatinasanexample
AT xiāoshījìng marketingstrategyofgenericmedicinesintaiwanundertheglobalbudgetsofthebnhiusingstatinasanexample
_version_ 1718295492798971904